Roswitha Forstpointner
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 31
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 21
- Oncology top 2%
- Viral-associated cancers and disorders 11
- CAR-T cell therapy research 2
- Neurology top 10%
- CNS Lymphoma Diagnosis and Treatment 6
- Dermatology top 5%
- Cutaneous lymphoproliferative disorders research 6
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Chronic Myeloid Leukemia Treatments 2
- Co-authors
- Wolfgang HiddemannMichael UnterhaltMartin DreylingBernd MetznerHermann EinseleJohn F. SeymourChristiane PottEva Hoster
- Partner nations
- GermanyNetherlandsAustralia
In The Last Decade
Roswitha Forstpointner
36 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 59
- Pathology and Forensic Medicine 1.5k
- Genetics 732
- Oncology 1.1k
- Neurology 188
- Dermatology 98
Countries citing papers authored by Roswitha Forstpointner
This map shows the geographic impact of Roswitha Forstpointner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roswitha Forstpointner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roswitha Forstpointner more than expected).
Fields of papers citing papers by Roswitha Forstpointner
This network shows the impact of papers produced by Roswitha Forstpointner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roswitha Forstpointner. The network helps show where Roswitha Forstpointner may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roswitha Forstpointner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2022 | 1 | |
| 3 | 2018 | 144 | |
| 4 | Immunochemotherapy With Obinutuzumab Or Rituximab In Previously Untreated Follicular Lymphoma In The Randomized Phase III Gallium Study: Analysis By Chemotherapy Regimen | 2017 | 1 |
| 5 | 2013 | 3 | |
| 6 | 2012 | 1 | |
| 7 | 2011 | 2 | |
| 8 | Rituximab maintenance after combined immuno-chemotherapy significantly prolongs duration of remission in elderly patients with mantle cell lymphoma | 2011 | 2 |
| 9 | 2009 | 31 | |
| 10 | 2008 | 10 | |
| 11 | 2008 | 14 | |
| 12 | 2006 | 336 | |
| 13 | 2006 | 13 | |
| 14 | 2005 | 6 | |
| 15 | 2004 | 445 | |
| 16 | Rituximab zur Remissionsinduktion bei rezidivierten und refraktaeren indolenten Lymphomen und Mantelzell-Lymphomen: Ergebnisse einer prospektiv randomisierten Studie der deutschen Studiengruppe fuer niedrig maligne Lymphome (GLSG) | 2002 | 1 |
| 17 | 2002 | 6 | |
| 18 | The addition of rituximab to combination chemotherapy with fludarabine, cyclophosphamide, mitoxantrone (FCM) results in a significant increase of overall response as compared to FCM alone in patients with relapsed or refractory follicular (FCL) and mantel cell lymphomas (MCL) - Results of a prospective randomized comparison of the German low grade study group (GLSG). | 2001 | 0 |
| 19 | 2001 | 51 | |
| 20 | 1999 | 28 |
About Roswitha Forstpointner
Roswitha Forstpointner is a scholar working on Genetics, Pathology and Forensic Medicine and Dermatology, having authored 38 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (31 papers), Chronic Lymphocytic Leukemia Research (21 papers), Viral-associated cancers and disorders (11 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), Cutaneous lymphoproliferative disorders research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), CAR-T cell therapy research (2 papers) and Chronic Myeloid Leukemia Treatments (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.5k citations), Genetics (732 citations) and Oncology (1.1k citations). Roswitha Forstpointner has collaborated with scholars based in Germany, Netherlands and Australia. Frequent co-authors include Wolfgang Hiddemann, Michael Unterhalt, Martin Dreyling, Bernd Metzner, Hermann Einsele, John F. Seymour, Christiane Pott, Eva Hoster, H. Wandt and Roland Repp. Their work appears in journals such as Blood, Journal of Clinical Oncology, Haematologica, Annals of Oncology and Current Hematologic Malignancy Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.